Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 681352, 10 pages
http://dx.doi.org/10.1155/2014/681352
Research Article

Ethyl Acetate Extract of Artemisia anomala S. Moore Displays Potent Anti-Inflammatory Effect

Shanghai University of Traditional Chinese Medicine, Pudong, Shanghai 201203, China

Received 8 January 2014; Accepted 4 February 2014; Published 12 March 2014

Academic Editor: Kam-Ming Ko

Copyright © 2014 Xi Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Lopes-Lutz, D. S. Alviano, C. S. Alviano, and P. P. Kolodziejczyk, “Screening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils,” Phytochemistry, vol. 69, no. 8, pp. 1732–1738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Tu, “The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine,” Nature Medicine, vol. 17, no. 10, pp. 1217–1220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Liao, L. K. Banbury, and D. N. Leach, “Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics,” Evidence-based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 429–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Zheng, “An experimental study of the anti-HSV-II action of 500 herbal drugs,” Journal of Traditional Chinese Medicine, vol. 9, no. 2, pp. 113–116, 1989. View at Google Scholar · View at Scopus
  5. J. Wen, H. Shi, Z. Xu et al., “Dimeric guaianolides and sesquiterpenoids from Artemisia anomala,” Journal of Natural Products, vol. 73, no. 1, pp. 67–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Zan, S.-X. Zhou, X.-Q. Chen, Q. Fu, and P.-F. Tu, “Prostaglandin-like fatty acid derivatives from Artemisia anomala,” Journal of Asian Natural Products Research, vol. 12, no. 6, pp. 492–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. R. Ropelle, J. R. Pauli, D. E. Cintra et al., “Targeted disruption of inducible nitric oxide synthase protects against aging, S-nitrosation, and insulin resistance in muscle of male mice,” Diabetes, vol. 62, no. 2, pp. 466–470, 2013. View at Google Scholar
  8. S. S. Darwiche, R. Pfeifer, C. Menzel et al., “Inducible nitric oxide synthase contributes to immune dysfunction following trauma,” Shock, vol. 38, no. 5, pp. 499–507, 2012. View at Google Scholar
  9. K. Bian, F. Ghassemi, A. Sotolongo et al., “NOS-2 signaling and cancer therapy,” IUBMB Life, vol. 64, no. 8, pp. 676–683, 2012. View at Google Scholar
  10. M. J. Alcaraz and M. I. Guillén, “Nitric oxide related therapeutic phenomenon: a challenging task,” Current Pharmaceutical Design, vol. 8, no. 3, pp. 215–231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Bian and F. Murad, “Nitric oxide (NO)—Biogeneration, regulation, and relevence to human diseases,” Frontiers in Bioscience, vol. 8, pp. d264–d278, 2003. View at Google Scholar · View at Scopus
  12. C. J. Lowenstein and E. Padalko, “iNOS (NOS2) at a glance,” Journal of Cell Science, vol. 117, no. 14, pp. 2865–2867, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Bonizzl, E. Dejardin, B. Piret, J. Piette, M.-P. Merville, and V. Bours, “Interleukin-1β induces nuclear factor κB in epithelial cells independently of the production of reactive oxygen intermediates,” European Journal of Biochemistry, vol. 242, no. 3, pp. 544–549, 1996. View at Google Scholar · View at Scopus
  14. B. Dawn, Y.-T. Xuan, Y. Guo et al., “IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2,” Cardiovascular Research, vol. 64, no. 1, pp. 61–71, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Speranza, S. Franceschelli, M. Pesce et al., “Negative feedback interaction of HO-1/INOS in PBMC of acute congestive heart failure patients,” Journal of Biological Regulators & Homeostatic Agents, vol. 27, no. 3, pp. 739–748, 2013. View at Google Scholar
  16. S. W. Ryter, J. Alam, and A. M. K. Choi, “Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications,” Physiological Reviews, vol. 86, no. 2, pp. 583–650, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Gozzelino, V. Jeney, and M. P. Soares, “Mechanisms of cell protection by heme Oxygenase-1,” Annual Review of Pharmacology and Toxicology, vol. 50, pp. 323–354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. N. G. Abraham, A. Asija, G. Drummond, and S. Peterson, “Heme oxygenase -1 gene therapy: recent advances and therapeutic applications,” Current Gene Therapy, vol. 7, no. 2, pp. 89–108, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Chen, X. Shen, S. Cheng et al., “Evaluation of garlic cultivars for polyphenolic content and antioxidant properties,” PLoS One, vol. 8, no. 11, article e79730, 2013. View at Google Scholar
  20. L. Zhao, J.-Y. Tao, S.-L. Zhang et al., “Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb,” Inflammation, vol. 30, no. 6, pp. 213–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. L. Chen and D. D. Zhang, “Anti-inflammatory effects of 81 Chinese herb extracts and their correlation with the characteristics of Traditional Chinese Medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 985176, 8 pages, 2014. View at Publisher · View at Google Scholar
  22. F. Aktan, “iNOS-mediated nitric oxide production and its regulation,” Life Sciences, vol. 75, no. 6, pp. 639–653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Kleinert, A. Pautz, K. Linker, and P. M. Schwarz, “Regulation of the expression of inducible nitric oxide synthase,” European Journal of Pharmacology, vol. 500, no. 1–3, pp. 255–266, 2004. View at Google Scholar
  24. W. Wongchana and T. Palaga, “Direct regulation of interleukin-6 expression by Notch signaling in macrophages,” Cellular and Molecular Immunology, vol. 9, no. 2, pp. 155–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. K. Glass and K. Saijo, “Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells,” Nature Reviews Immunology, vol. 10, no. 5, pp. 365–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Zhang and S. Ghosh, “Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors,” Journal of Endotoxin Research, vol. 6, no. 6, pp. 453–457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. F. Valledor and M. Ricote, “Nuclear receptor signaling in macrophages,” Biochemical Pharmacology, vol. 67, no. 2, pp. 201–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Cuzzocrea, E. Mazzon, G. Calabro et al., “Inducible nitric oxide synthase—Knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 5, pp. 1859–1866, 2000. View at Google Scholar · View at Scopus
  29. N. L. McCartney-Francis, X.-Y. Song, D. E. Mizel, and S. M. Wahl, “Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease,” Journal of Immunology, vol. 166, no. 4, pp. 2734–2740, 2001. View at Google Scholar · View at Scopus
  30. D. C. Hooper, O. Bagasra, J. C. Marini et al., “Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 6, pp. 2528–2533, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. C. V. Rao, C. Indranie, B. Simi, P. T. Manning, J. R. Connor, and B. S. Reddy, “Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor,” Cancer Research, vol. 62, no. 1, pp. 165–170, 2002. View at Google Scholar · View at Scopus
  32. L. L. Thomsen, J. M. J. Scott, P. Topley, R. G. Knowles, A.-J. Keerie, and A. J. Frend, “Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400 W, a novel inhibitor,” Cancer Research, vol. 57, no. 15, pp. 3300–3304, 1997. View at Google Scholar · View at Scopus
  33. A. Paine, B. Eiz-Vesper, R. Blasczyk, and S. Immenschuh, “Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential,” Biochemical Pharmacology, vol. 80, no. 12, pp. 1895–1903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Hambleton, S. L. Weinstein, L. Lem, and A. L. Defranco, “Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 7, pp. 2774–2778, 1996. View at Google Scholar · View at Scopus
  35. E. D. Chan and D. W. H. Riches, “IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38mapk in a mouse macrophage cell line,” American Journal of Physiology—Cell Physiology, vol. 280, no. 3, pp. C441–C450, 2001. View at Google Scholar · View at Scopus
  36. B. L. Fiebich, K. Lieb, S. Engels, and M. Heinrich, “Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells,” Journal of Neuroimmunology, vol. 132, no. 1-2, pp. 18–24, 2002. View at Publisher · View at Google Scholar · View at Scopus